FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2031465452> ?p ?o ?g. }

• W2031465452 endingPage "265" @default.
• W2031465452 startingPage "251" @default.
• W2031465452 abstract "Cells possess within their epigenetic repertoire the ability to undergo an active process of cellular suicide termed programmed (or apoptotic) cell death. This programmed cell death process involves an epigenetic reprogramming of the cell that results in an energy-dependent cascade of biochemical and morphologic changes (also termed apoptosis) within the cell, resulting in its death and elimination. Although the final steps (i.e., DNA and cellular fragmentation) are common to cells undergoing programmed cell death, the activation of this death process is initiated either by sufficient injury to the cell induced by various exogenous damaging agents (e.g., radiation, chemicals, viruses) or by changes in the levels of a series of endogenous signals (e.g., hormones and growth/survival factors). Within the prostate, androgens are capable of both stimulating proliferation as well as inhibiting the rate of the glandular epithelial cell death. Androgen withdrawal triggers the programmed cell death pathway in both normal prostate glandular epithelia and androgen-dependent prostate cancer cells. Androgen-independent prostate cancer cells do not initiate the programmed cell death pathway upon androgen ablation; however, they do retain the cellular machinery necessary to activate the programmed cell death cascade when sufficiently damaged by exogenous agents. In the normal prostate epithelium, cell proliferation is balanced by an equal rate of programmed cell death, such that neither involution nor overgrowth normal occurs. In prostatic cancer, however, this balance is lost, such that there is greater proliferation than death producing continuous net growth. Thus, an imbalance in programmed cell death must occur during prostatic cancer progression. The goal of effective therapy for prostatic cancer, therefore, is to correct this imbalance. Unfortunately, this has not been achieved and metastatic prostatic cancer is still a lethal disease for which no curative therapy is currently available. In order to develop such effective therapy, an understanding of the programmed death pathway, and what controls it, is critical. Thus, a review of the present state of knowledge concerning programmed cell death of normal and malignant prostatic cells will be presented. © 1996 Wiley-Liss, Inc." @default.
• W2031465452 created "2016-06-24" @default.
• W2031465452 creator A5001771354 @default.
• W2031465452 creator A5015506184 @default.
• W2031465452 creator A5043265453 @default.
• W2031465452 date "1996-04-01" @default.
• W2031465452 modified "2023-10-12" @default.
• W2031465452 title "Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer" @default.
• W2031465452 cites W127934333 @default.
• W2031465452 cites W1488722525 @default.
• W2031465452 cites W1531387663 @default.
• W2031465452 cites W1535775317 @default.
• W2031465452 cites W155569352 @default.
• W2031465452 cites W156326090 @default.
• W2031465452 cites W1585215116 @default.
• W2031465452 cites W1589415602 @default.
• W2031465452 cites W1591166893 @default.
• W2031465452 cites W1593385535 @default.
• W2031465452 cites W1608453530 @default.
• W2031465452 cites W1845134010 @default.
• W2031465452 cites W1865508414 @default.
• W2031465452 cites W1971234510 @default.
• W2031465452 cites W1974667009 @default.
• W2031465452 cites W1977871779 @default.
• W2031465452 cites W1984332162 @default.
• W2031465452 cites W1986855888 @default.
• W2031465452 cites W1990781244 @default.
• W2031465452 cites W1994320352 @default.
• W2031465452 cites W1995142571 @default.
• W2031465452 cites W1998579531 @default.
• W2031465452 cites W2002599993 @default.
• W2031465452 cites W2005182680 @default.
• W2031465452 cites W2006493954 @default.
• W2031465452 cites W2008898220 @default.
• W2031465452 cites W2009183764 @default.
• W2031465452 cites W2010298858 @default.
• W2031465452 cites W2010504637 @default.
• W2031465452 cites W2011275029 @default.
• W2031465452 cites W2013464193 @default.
• W2031465452 cites W2014145760 @default.
• W2031465452 cites W2017700331 @default.
• W2031465452 cites W2019240309 @default.
• W2031465452 cites W2019490921 @default.
• W2031465452 cites W2019514805 @default.
• W2031465452 cites W2020397573 @default.
• W2031465452 cites W2027925208 @default.
• W2031465452 cites W2029808948 @default.
• W2031465452 cites W2029818609 @default.
• W2031465452 cites W2030312997 @default.
• W2031465452 cites W2032490803 @default.
• W2031465452 cites W2033847504 @default.
• W2031465452 cites W2039539461 @default.
• W2031465452 cites W2052853635 @default.
• W2031465452 cites W2054642769 @default.
• W2031465452 cites W2057257609 @default.
• W2031465452 cites W2058591356 @default.
• W2031465452 cites W2062413760 @default.
• W2031465452 cites W2063535351 @default.
• W2031465452 cites W2073415946 @default.
• W2031465452 cites W2076702926 @default.
• W2031465452 cites W2078581194 @default.
• W2031465452 cites W2081145901 @default.
• W2031465452 cites W2081197593 @default.
• W2031465452 cites W2084565769 @default.
• W2031465452 cites W2084609653 @default.
• W2031465452 cites W2089579900 @default.
• W2031465452 cites W2090898609 @default.
• W2031465452 cites W2103286437 @default.
• W2031465452 cites W2120435603 @default.
• W2031465452 cites W2134979684 @default.
• W2031465452 cites W2138302361 @default.
• W2031465452 cites W2158743409 @default.
• W2031465452 cites W2178615409 @default.
• W2031465452 cites W2341581173 @default.
• W2031465452 cites W3025291113 @default.
• W2031465452 cites W38078248 @default.
• W2031465452 cites W4323284712 @default.
• W2031465452 doi "https://doi.org/10.1002/(sici)1097-0045(199604)28:4<251::aid-pros6>3.0.co;2-g" @default.
• W2031465452 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8602401" @default.
• W2031465452 hasPublicationYear "1996" @default.
• W2031465452 type Work @default.
• W2031465452 sameAs 2031465452 @default.
• W2031465452 citedByCount "404" @default.
• W2031465452 countsByYear W20314654522012 @default.
• W2031465452 countsByYear W20314654522013 @default.
• W2031465452 countsByYear W20314654522014 @default.
• W2031465452 countsByYear W20314654522015 @default.
• W2031465452 countsByYear W20314654522016 @default.
• W2031465452 countsByYear W20314654522017 @default.
• W2031465452 countsByYear W20314654522018 @default.
• W2031465452 countsByYear W20314654522019 @default.
• W2031465452 countsByYear W20314654522020 @default.
• W2031465452 countsByYear W20314654522021 @default.
• W2031465452 countsByYear W20314654522022 @default.
• W2031465452 countsByYear W20314654522023 @default.
• W2031465452 crossrefType "journal-article" @default.
• W2031465452 hasAuthorship W2031465452A5001771354 @default.
• W2031465452 hasAuthorship W2031465452A5015506184 @default.

• next